Platelet-Derived Exosomes IV Infusion

Human Continuum's Platelet-Derived Exosomes IV Infusion, also referred to as Flagship, is a cell-free biologic therapy designed for systemic administration. The product consists of exosomes harvested from platelets, which are rich in regenerative growth factors, lipids, and signaling RNAs. By delivering this cargo via intravenous infusion, the therapy aims to modulate systemic inflammation, optimize cellular health, and promote tissue rejuvenation. It is primarily targeted at longevity and the treatment of chronic inflammatory states, representing a shift toward cell-free regenerative medicine by leveraging paracrine signaling to stimulate repair processes without the use of live cells.

Brand names

Flagship

Other names

Platelet-Derived ExosomesHuman Continuum Exosome TherapyCell-Free Biologic IV Infusion